Differentiated thyroid cancer in patients over 60 years of age at presentation: A retrospective study of 438 patients. Issue 1 (January 2015)
- Record Type:
- Journal Article
- Title:
- Differentiated thyroid cancer in patients over 60 years of age at presentation: A retrospective study of 438 patients. Issue 1 (January 2015)
- Main Title:
- Differentiated thyroid cancer in patients over 60 years of age at presentation: A retrospective study of 438 patients
- Authors:
- Garg, Aayushi
Chopra, Saurav
Ballal, Sanjana
Soundararajan, Ramya
Bal, C.S. - Abstract:
- <abstract abstract-type="author" id="ab0005"> <title id="st0005">Abstract</title> <sec> <title id="st0010">Objectives</title> <p id="sp0005">The aim of this study is to identify the prognostic factors predicting remission and subsequent disease relapse in patients with differentiated thyroid cancer (DTC) greater than 60 years of age.</p> </sec> <sec> <title id="st0015">Materials and Methods</title> <p id="sp0010">The institute thyroid cancer database had 4370 patients with DTC, of which 447 (10%) were aged &gt; 60. However, 9 patients were excluded due to follow-up less than 1 year. The prognostic factors in the remaining 438 patients were studied.</p> </sec> <sec> <title id="st0020">Results</title> <p id="sp0015">Among the 438 patients, 311 (71%) had only loco-regional disease (M<sub>0</sub>) and 127 (29%) had distant metastases (M<sub>1</sub>) at the time of initial presentation. The host factors predictive of distant metastases at presentation were female gender, primary tumor size (&gt; 4 cm), follicular histology, and extra-thyroidal extension. Among M<sub>o</sub> patients, 195 (63%) achieved complete remission while only 12 (9%) M<sub>1</sub> patients did so. Average number of radioactive iodine (<sup>131</sup>I) doses administered to achieve complete remission was 2.3 (range, 1–6) and the mean cumulative dose was 3404 MBq (range, 925–46, 250 MBq). In multivariate logistic regression among M<sub>0</sub> patients, follicular histology, nodal metastases, and surgical<abstract abstract-type="author" id="ab0005"> <title id="st0005">Abstract</title> <sec> <title id="st0010">Objectives</title> <p id="sp0005">The aim of this study is to identify the prognostic factors predicting remission and subsequent disease relapse in patients with differentiated thyroid cancer (DTC) greater than 60 years of age.</p> </sec> <sec> <title id="st0015">Materials and Methods</title> <p id="sp0010">The institute thyroid cancer database had 4370 patients with DTC, of which 447 (10%) were aged &gt; 60. However, 9 patients were excluded due to follow-up less than 1 year. The prognostic factors in the remaining 438 patients were studied.</p> </sec> <sec> <title id="st0020">Results</title> <p id="sp0015">Among the 438 patients, 311 (71%) had only loco-regional disease (M<sub>0</sub>) and 127 (29%) had distant metastases (M<sub>1</sub>) at the time of initial presentation. The host factors predictive of distant metastases at presentation were female gender, primary tumor size (&gt; 4 cm), follicular histology, and extra-thyroidal extension. Among M<sub>o</sub> patients, 195 (63%) achieved complete remission while only 12 (9%) M<sub>1</sub> patients did so. Average number of radioactive iodine (<sup>131</sup>I) doses administered to achieve complete remission was 2.3 (range, 1–6) and the mean cumulative dose was 3404 MBq (range, 925–46, 250 MBq). In multivariate logistic regression among M<sub>0</sub> patients, follicular histology, nodal metastases, and surgical treatment lesser than total/near-total thyroidectomy and among M<sub>1</sub> patients, site of distant metastases (skeletal and multiple sites) were independent factors predicting non-remission. Among the patients (both M<sub>0</sub> and M<sub>1</sub>) who achieved remission, factors associated with disease recurrence were primary tumor size (&gt; 4 cm), nodal metastases, pulmonary metastases, and non-remission after first dose of radioactive iodine and were associated with greater chances of disease relapse.</p> </sec> <sec> <title id="st0025">Conclusion</title> <p id="sp0020">This study highlights that DTC in older patients behaves more aggressively than in adults age &lt; 60 years, and identifies several prognostic factors for remission and subsequent relapse.</p> </sec> </abstract> … (more)
- Is Part Of:
- Journal of geriatric oncology. Volume 6:Issue 1(2015)
- Journal:
- Journal of geriatric oncology
- Issue:
- Volume 6:Issue 1(2015)
- Issue Display:
- Volume 6, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 6
- Issue:
- 1
- Issue Sort Value:
- 2015-0006-0001-0000
- Page Start:
- 29
- Page End:
- 37
- Publication Date:
- 2015-01
- Subjects:
- Geriatric oncology -- Periodicals
Neoplasms -- Periodicals
Aged -- Periodicals
Geriatric oncology
Electronic journals
Periodicals
618.976994005 - Journal URLs:
- http://www.clinicalkey.com.au/dura/browse/journalIssue/18794068 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/18794068 ↗
http://www.sciencedirect.com/science/journal/18794068 ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/j.jgo.2014.09.182 ↗
- Languages:
- English
- ISSNs:
- 1879-4068
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4372.xml